Showing results (971-980 of 1,104) with videos related to

Sort By:
Pageof 111
Pharmacological Research|June 24, 2022
Preferential Gs protein coupling of the galanin Gal<sub>1</sub> receptor in the µ-opioid-Gal<sub>1</sub> receptor heterotetramerPaulo A De Oliveira, Estefanía Moreno, Nil Casajuana-Martin, et al.
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2012
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy eraSean E McGuire, Andrew K Lee, Jasmina Z Cerne, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.
European Journal of Preventive Cardiology|March 28, 2026
Using population-wide electronic health records for timely contemporary assessment of cardiovascular disease risk prediction model performance: COVID-19 impact on the SCORE2 modelsCarmen Petitjean, Spencer J Keene, Thomas Bolton, et al.
Transplantation and Cellular Therapy|March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell LymphomaAbu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Developmental Cell|June 7, 2017
Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate CancerSong-Chang Lin, Yu-Chen Lee, Guoyu Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2013
Platinum-based chemotherapy for variant castrate-resistant prostate cancerAna M Aparicio, Andrea L Harzstark, Paul G Corn, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2016
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicitiesSumit K Subudhi, Ana Aparicio, Jianjun Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate CancerAndreas Varkaris, Paul G Corn, Nila U Parikh, et al.
Pageof 111